FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

AvKARE chloroproMAZINE Hydrochloride Tablets Recall

chloroproMAZINE Hydrochloride Tablets, USP, 100 mg, 50 Tablets (5x10) unit dose carton,…

AvKARE · Pulaski, TN

Risk level
Class II
Reported by FDA
Sep 17, 2025
Recall ID
D-0644-2025
Check your lot numberHow we source this data

Summary

AvKARE recalled chloroproMAZINE Hydrochloride Tablets starting Aug 25, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0644-2025 on Sep 17, 2025. Reason: Presence of a foreign substance. Status: Ongoing.

Why it was recalled

Presence of a foreign substance.

Product description

chloroproMAZINE Hydrochloride Tablets, USP, 100 mg, 50 Tablets (5x10) unit dose carton, Rx only, Manufactured for: AvKare, Pulaski, TN, 38478, NDC 50268-165-15

Lot numbers, UPCs & expiration codes

Lot # 47089, Exp 12/31/25; 47604, Exp 03/31/26

Where it was sold

USA Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0644-2025
Classification
Class II
Status
Ongoing
Recall initiated
Aug 25, 2025
FDA report date
Sep 17, 2025
Quantity
2003 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
AvKARE

Original FDA data

Every field from FDA enforcement report D-0644-2025, exactly as published.

Show all FDA fields
City
Pulaski
State
TN
Status
Ongoing
Country
United States
Event ID
97548
Address
615 N 1st St
Code information
Lot # 47089, Exp 12/31/25; 47604, Exp 03/31/26
Postal code
38478-2403
Report date
Sep 17, 2025
Product type
Drugs
Recall number
D-0644-2025
Classification
Class II
Recalling firm
AvKARE
Product quantity
2003 cartons
Reason for recall
Presence of a foreign substance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
chloroproMAZINE Hydrochloride Tablets, USP, 100 mg, 50 Tablets (5x10) unit dose carton, Rx only, Manufactured for: AvKare, Pulaski, TN, 38478, NDC 50268-165-15
Distribution pattern
USA Nationwide
Recall initiation date
Aug 25, 2025
Initial firm notification
E-Mail
Center classification date
Sep 11, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0644-2025, published Sep 17, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls